By Team

MIAMI (CBSMiami) – Gilead, the maker of remdesivir, the first antiviral approved to treat COVID-19, is announcing a safety recall.

In a statement, the company reports that two lots of its COVID-19 drug remdesivir may be contaminated with glass particles.

READ MORE: Deadly Crash Shuts Down Deerfield Beach Streets; BSO Cruiser Towed From Scene

While there have been no adverse events reported, in theory, the particles could block blood vessels causing stroke and even death.

READ MORE: Judge Ketanji Brown Jackson, Who Grew Up In Miami, Could Be Next US Supreme Court Justice

Gilead is notifying distributors and customers about the problem.

The infused anti-viral treatment can only be administered in a controlled health care setting like a hospital.

MORE NEWS: Miami Twin Brothers Will Set Sail For Harvard In The Fall

Remdesivir is sold under the brand name Veklury and was approved by the FDA for treating hospitalized COVID-19 patients 12 years and older. Team